AAV-ICAM2-EGFP (AAV Serotype BI30)

Product Category: Pre-made recombinant AAV | AAV-ICAM2-EGFP | AAV(BI30)-ICAM2-EGFP | AAV-ICAM2-GFP | AAV(BI30)-ICAM2-GFP
Description:
AAV(BI30)-ICAM2-EGFP is a pre-made recombinant adeno-associated virus engineered to express enhanced green fluorescent protein (eGFP) under the control of the mouse ICAM2 promoter, enabling preferential transgene expression in vascular endothelial cells. Packaged in the AAV(BI30) capsid, this vector exhibits enhanced tropism for central nervous system (CNS) endothelial cells in permissive mouse strains, making it a valuable tool for studies of the blood-brain barrier (BBB), cerebrovascular biology, endothelial gene function, and CNS-targeted gene delivery.
This vector is produced using our helper-free AAV packaging system, purified by CsCl gradient ultracentrifugation, and supplied in a ready-to-use format at >1 × 10¹³ VG/mL (in vivo grade). Each lot undergoes rigorous quality control, including vector genome titration by qPCR using an ATCC reference AAV standard, to ensure high purity, consistency, and reliable performance. The ICAM2 promoter provides endothelial-enriched expression while minimizing off-target transgene expression, and the eGFP reporter enables convenient visualization and quantification of transduced cells by fluorescence microscopy, flow cytometry, or histological analysis.
Titer: >1E+13 VG/mL
Size: 30 µL (Std Pack)
Reconstitution Buffer: Sterile PBS supplemented with final 0.005% Pluronic F-68 and 200 mM NaCl
CITATIONS
| Shipping Weight | 6 lbs |
|---|---|
| Unit Size | 30 µL at >10¹³ VG/mL, 10 µL at >10¹³ VG/mL |
Customers who bought this product also purchased…
- SL100832AAV-Null (AAV Serotype 8)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
Custom Service Solutions
Looking for a customized solution? Our end-to-end capabilities support both in vitro and in vivo applications, with rigorous quality control, scalable production processes, and expert scientific oversight at every stage.

